BioXcel Therapeutics, Inc.
BTAI
$1.18
-$0.02-1.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -21.45% | 107.49% | -43.78% | 3.88% | -26.08% |
| Total Receivables | -- | -- | -- | -- | 4,266.67% |
| Inventory | 57.30% | -9.29% | -21.18% | -5.45% | -55.48% |
| Prepaid Expenses | -29.21% | 10.49% | 8.72% | -10.45% | 18.11% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 443.17% | -2.67% | 54.15% | -3.82% | 3.00% |
| Total Current Assets | 0.64% | 75.90% | -33.18% | 1.02% | -21.76% |
|
|
|||||
| Total Current Assets | 0.64% | 75.90% | -33.18% | 1.02% | -21.76% |
| Net Property, Plant & Equipment | -40.62% | -28.75% | -22.22% | -18.09% | -15.40% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 0.00% | 0.00% |
| Total Assets | 0.28% | 73.69% | -33.13% | 0.59% | -21.59% |
|
|
|||||
| Total Accounts Payable | -9.68% | -2.49% | 8.04% | -3.38% | 7.39% |
| Total Accrued Expenses | 1.48% | -14.15% | 30.47% | -32.29% | -32.57% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 47.17% | 48.05% | 92.55% | -- | -- |
| Total Finance Division Other Current Liabilities | 5,938.27% | 50.00% | -52.21% | -51.40% | -73.14% |
| Total Other Current Liabilities | 5,938.27% | 50.00% | -52.21% | -51.40% | -73.14% |
| Total Current Liabilities | 42.65% | 13.27% | 30.65% | 14.90% | -13.01% |
|
|
|||||
| Total Current Liabilities | 42.65% | 13.27% | 30.65% | 14.90% | -13.01% |
| Long-Term Debt | -8.28% | -5.30% | -2.45% | -2.53% | -1.85% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -59.63% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -50.35% | 38.07% | -20.25% | -50.64% | 51.89% |
| Total Liabilities | 4.99% | 0.19% | 3.66% | -2.05% | -2.29% |
|
|
|||||
| Common Stock & APIC | 0.97% | 8.73% | 0.30% | 1.83% | 0.61% |
| Retained Earnings | -1.77% | -4.57% | -2.92% | -1.12% | -1.70% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -7.36% | 17.41% | -19.40% | 3.15% | -8.72% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.36% | 17.41% | -19.40% | 3.15% | -8.72% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.36% | 17.41% | -19.40% | 3.15% | -8.72% |
|
|
|||||